Doctor profile · Federal record

Dr. Brinda Manchireddy, M.D

Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Student in an Organized Health Care Education/Training Program · Fredricksburg, VA

  • NPI 1447606488
  • Accepts Medicare
  • 11 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1101 Sam Perry Blvd #305
Fredricksburg, VA 22401
(540) 374-3290
fax (540) 374-3289

Credentials & registration

NPPES · NUCC
NPI registered
May 2016 — 10 yrs on file
Profile last updated
July 26, 2022
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Virginia #0101271645

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1447606488. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,235
Distinct HCPCS
8
Medicare allowed
$111,707
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 1,500 15 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 393 206 $121
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 109 43 $77
99204 New patient office or other outpatient visit, 45-59 minutes 61 61 $157
99213 Established patient office or other outpatient visit, 20-29 minutes 60 46 $84
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 52 33 $32
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 35 34 $127
96372 Injection of drug or substance under skin or into muscle 25 15 $14

In context: peer comparison

Among 1 peers in this city , average services per provider: 279. This provider delivers 8.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$772
Transactions
33
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
SANOFI-AVENTIS U.S. LLC 3 $98.09
Novo Nordisk Inc 4 $85.45
IBSA Pharma Inc. 3 $72.38
Lilly USA, LLC 3 $65.55
Xeris Pharmaceuticals, Inc. 3 $63.40
Amgen Inc. 3 $56.15
Radius Health, Inc. 2 $49.22
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $46.08
Abbott Laboratories 2 $44.92
Corcept Therapeutics 2 $41.05
RECORDATI_RARE_DISEASES_INC. 2 $39.45
Medtronic, Inc. 1 $25.10
BETA BIONICS, INC. 1 $22.95
Insulet Corporation 1 $20.79
Bayer Healthcare Pharmaceuticals Inc. 1 $16.32

By nature of payment

Food and Beverage
$772

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,572
Patients
472
Total drug cost
$1,191,777
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 278 76 $4,546
Trulicity (Dulaglutide) Brand 204 50 $454,298
Metformin Hcl Generic 159 47 $1,447
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 149 49 $135,638
Atorvastatin Calcium Generic 138 45 $1,705
Rosuvastatin Calcium Generic 97 35 $2,263
Ozempic (Semaglutide) Brand 79 20 $129,581
Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) Brand 75 39 $10,541
Jardiance (Empagliflozin) Brand 68 20 $103,463
Mounjaro (Tirzepatide) Brand 63 13 $123,937

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Brinda Manchireddy's medical specialty?
Dr. Brinda Manchireddy practices Endocrinology, Diabetes & Metabolism Physician in Fredricksburg, VA.
Where does Dr. Brinda Manchireddy practice?
Dr. Brinda Manchireddy practices at 1101 Sam Perry Blvd #305, Fredricksburg, VA 22401. Office phone: 5403743290.
What is Dr. Brinda Manchireddy's NPI?
Dr. Brinda Manchireddy's National Provider Identifier (NPI) is 1447606488, issued by NPPES.
Does Dr. Brinda Manchireddy accept Medicare assignment?
Yes. Dr. Brinda Manchireddy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brinda Manchireddy commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.